Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure

British Journal of Pharmacology

Volumn 127, Issue 7, 1999, Pages 1671-1679

  Litwin, Sheldon E ^a,b,d   Katz, Sarah E ^c   Morgan, James P ^c   Douglas, Pamela S ^c  

^a Cardiovascular Division   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Beta adrenergic receptors; Blood flow velocity; Calcium; Congestive; Diastole; Echocardiography; Heart failure; Myocardial contractility; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; AEQUORIN; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; HEART; HEART FAILURE, CONGESTIVE; ISOMETRIC CONTRACTION; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; PAPILLARY MUSCLES; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 0032794722     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702701     Document Type: Article

References (44)

1. ANDERSSON, B., BLOMSTROM-LUNDQVIST, C., HEDNER, T. & WAAGSTEIN, F. (1991). Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J. Am. Coll. Cardiol., 18, 1059-1066.
2. APPLETON, C., HATLE, L. & POPP, R. (1988). Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and echocardiographic study. J. Am. Coll. Cardiol., 12, 426-440.
3. AUSTRALIA, NEW ZEALAND HEART FAILURE RESEARCH COLLABORATIVE GROUP. (1997). Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet, 349, 375-380.
4. BART, B.A., SHAW, L.K., McCANTS, C.B., FORTIN, D.F., LEE, K.L., CALIFF, R.M. & O'CONNOR, C.M. (1997). Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J. Am. Coll. Cardiol., 30, 1002-1008.
5. BETA BLOCKER HEART ATTACK TRIAL RESEARCH GROUP. (1982). A randomized trial of propranolol in patients with acute myocardial infarction. JAMA, 247, 1707-1713.
6. BOHM, M., ETTELBRUCK, S., FLESCH, M., VAN GILST, W.H., KNORR, A., MAACK, C., PINTO, Y.M., PAUL, M., TEISMAN, A.C. & ZOLK, O. (1998). Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy. Cardiovasc. Res., 40, 146-155.
7. ix in human hearts with dilated but not ischemic cardiomyopathy. Circulation, 82, 1249-1265.
8. BRISTOW, M.R., ANDERSON, F.L., PORT, J.D., SKERL, L., HERSHBERGER, R.E., LARRABEE, P., O'CONNELL, J.B., RENLUND, D.G., VOLKMAN, K., MURRAY, J. & FELDMAN, A.M. (1991). Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation, 84, 1024-1039.
9. BRISTOW, M.R., GILBERT, E.M., ABRAHAM, W.T., ADAMS, K.F., FOWLER, M.B., HERSCHBERGER, R.E., KUBO, S.H., NARAHARA, K.A., INGERSOLL, H., KRUEGER, S., YOUNG, S. & SHUSTERMAN, N. (1996). Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 94, 2807-2816.
10. CHERNG, W.-J., LIANG, C.-S. & HOOD, W.B. (1994). Effects of metoprolol on left ventricular function in rats with myocardial infarction. Am. J. Physiol., 266, H787-H794.
11. DOHERTY, N.E., SEELOS, K.C., SUZUKI, J., CAPUTO, G.R., O'SULLIVAN, M., SOBOL, S.M., CAVERO, P., CHATERJEE, K., PARMLEY, W.W. & HIGGINS, C.B. (1992). Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J. Am. Coll. Cardiol., 19, 1294-1032.
12. DOUGHTY, R.N., WHALLEY, G.A., GAMBLE, G., MACMAHON, S. & SHARPE, N. (1997). Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J. Am. Coll. Cardiol., 29, 1060-1066.
13. EICHHORN, E.J., HEESCH, C.M., BARNETT, J.H., ALVAREZ, L.G., FASS, S.M., GRAYBURN, P.A., HATFIELD, B.A., MARCOUX, L.G. & MALLOY, C.R (1994). Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol., 24, 1310-1320.
14. EXNER, D.W., DRIES, D.L., WACLAWIW, M.A., SHELTON, B. & DOMANSKI, M.J. (1999). Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction [In Process Citation]. J. Am. Coll. Cardiol., 33, 916-923.
15. FEUERSTEIN, G., LIU, G.L., YUE, T.L., CHENG, H.Y., HIEBLE, J.P., ARCH, J.R., RUFFOLO, JR R.R. & MA, X.L. (1998). Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. Eur. J. Pharmacol., 351, 341-350.
16. FEUERSTEIN, G.Z., YUE, T.L., CHENG, H.Y. & RUFFOLO, R.R.J. (1993). Myocardial protection by the novel vasodilating beta-blocker carvedilol: potential relevance of antioxidant activity. J. Hypertension, 11, S41-S48.
17. FISHER, M.L., GOTTLIEB, S.S., PLOTNICK, G.D., GREENBERG, N.L., PATTEN, R.D., BENNETT, S.K. & HAMILTON, B.P. (1994). Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J. Am. Coll. Cardiol., 23, 943-950.
18. GAY, R.G., RAYA, T.E. & GOLDMAN, S. (1990). Chronic propranolol treatment promotes left ventricular dilatation without altering systolic function after large myocardial infarction in rats. J. Cardiovasc. Pharmacol., 16, 529-536.
19. GILBERT, E.M., ABRAHAM, W.T., OLSEN, S., HATTLER, B., WHITE, M., MEALY, P., LARRABEE, P. & BRISTOW, M.R. (1996). Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation, 94, 2817-2825.
20. HABER, H.L., SIMEK, C.L., GIMPLE, L.W., BERGIN, J.D., SUBBIAH, K., JAYAWEERA, A.R., POWERS, E.R. & FELDMAN, M.D. (1993). Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy? Circulation, 88, 1610-1619.
21. HAGAR, J.M., NEWMAN, L.G. & KLONER, R.A. (1992). Effects of amlodipine on myocardial infarction, infarct expansion, and ventricular geometry in the rat. Am. Heart J., 124, 571-580.
22. HALL, S.A., CIGARROA, C.G., MARCOUX, L., RISSER, R.C., GRAYBURN, P.A. & EICHORN, E.J. (1995). Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J. Am. Coll. Cardiol., 25, 1154-1161.
23. HEIDENREICH, P.A., LEE, T.T. & MASSIE, B.M. (1997). Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J. Am. Coll. Cardiol., 30, 27-34.
24. HODSMAN, G.P., KOHZUKI, M., HOWES, L.G., SUMITHRAN, E., TSUNODA, K. & JOHNSTON, C.I. (1988). Neurohumoral responses to chronic myocardial infarction in rats. Circulation, 78, 376-381.
25. HU, K., GAUDRON, P. & ERTL, G. (1998). Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. J. Am. Coll. Cardiol., 31, 692-700.
26. LITWIN, S.E., KATZ, S.E., MORGAN, J.P. & DOUGLAS, P.S. (1996). Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J. Am. Coll. Cardiol., 28, 773-781.
27. LITWIN, S.E., KATZ, S.E., MORGAN, J.P. & DOUGLAS, P.S. (1994). Serial echocardiographic assessment of left ventricular function after large myocardial infarction in the rat. Circulation, 89, 345-354.
28. LITWIN, S.E., LITWIN, C.M., RAYA, T.E., WARNER, A.W. & GOLDMAN, S. (1991). Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats: effects of chronic angiotensin converting enzyme inhibition. Circulation, 83, 1028-1037.
29. 2+ handling and β-adrenergic responsiveness of myocardium from rats with postinfarction heart failure. Circ. Res., 71, 797-807.
30. NORWEGIAN STUDY GROUP. (1981). Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med., 304, 801-807.
31. OPITZ, C.F., MITCHELL, G.F., PEEFFER, M.A. & PEEFFER, J.M. (1995). Arrhythmias and death after coronary artery occlusion in the rat: Continuous telemetric ECG monitoring in conscious untethered rats. Circulation, 92, 253-261.
32. PACKER, M., BRISTOW, M.R., COHN, J.N., COLUCCI, W.S., FOWLER, M.B., GILBERT E.M., SHUSTERMAN, N.H. & FOR THE U.S. CARVEDILOL HEART FAILURE STUDY GROUP. (1996). The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med., 334, 1349-1355.
33. PFEFFER, J.M., PFEFFER, M.A. & BRAUNWALD, E. (1985b). Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res., 57, 84-95.
34. PFEFFER, M.A., PFEFFER, J.M., FISHBEIN, M.C., FLETCHER, P.J., SPADARO, J., KLONER, R.A. & BRAUNWALD, E. (1979). Myocardial infarct size and ventricular function in rats. Circ. Res., 44, 503-512.
35. PFEFFER, M.A., PFEFFER, J.M., STEINBERG, C. & FINN, P. (1985a). Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation, 72, 406-412.
36. RAYA, T.E., LEE, R.W., WESTHOFF, T. & GOLDMAN, S. (1989). Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Circulation, 80, 1886-1892.
37. ROBERTS, R., ROGERS, W.J., MUELLER, H.S., LAMBREW, C.T., DIVER, D.J., SMITH, H.C., WILLERSON, J.T., KNATTERUD, G.L., FORMAN, S., PASSAMANI, E., ZARET, B.L., WACKERS, F.J.T., BRAUNWALD, E. & for the TIMI investigators. (1991). Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) II-B study. Circulation, 83, 422-437.
38. SCHUNKERT, H., TANG, S.S., LITWIN, S.E., DIAMANT, D., RIEGGER, G., DZAU, V.J. & INGELFINGER, J.R. (1993). Regulation of intrarenal and circulating renin angiotensin systems in severe heart failure in the rat. Cardiovasc. Res., 27, 731-735.
39. STEEDS, R.P. & CHANNER, K.S. (1997). Heart failure: vive la difference! Heart, 78, 537-538.
40. TEERLINK, J.R., LOFFLER, B.M., HESS, P., MAIRE, J.P., CLOZEL, M. & CLOZEL, J.P. (1994). Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation, 90, 2510-2518.
41. THE CIBIS INVESTIGATORS. (1994). A randomized trial of beta-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS). Circulation, 90, 1765-1773.
42. WAGNER, K.D., THERES, H., BORN, A., STRUBE, S., WUNDERLICH, N., PFITZER, G., BAUMANN, G. & GUNTHER, J. (1997). Contractile function of papillary muscle from rats with different infarct size after β-adrenergic blockade and ACE-inhibition. J. Mol. Cell. Cardiol., 29, 2941-2951.
43. WARNER, A.L., BELLAH, K.L., RAYA, T.E., ROESKE, W.R. & GOLDMAN, S. (1992). Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Circulation, 86, 1584-1595.
44. WOODLEY, S.L., GILBERT, E.M., ANDERSON, J.L., O'CONNELL, J.B., DEITCHMAN, D., YANOWITZ, F.G., MEALEY, P.C., VOLKMAN, K., RENLUNG, D.G., MENLOVE, R. & BRISTOW, M.R. (1991). β-blockade with bucindolol in heart failure caused by ischemic versus idiopapthic dilated cardiomyopathy. Circulation, 84, 2426-2441.